Synopsys (SNPS) Valuation Check After 25% Three‑Month Pullback in the Share Price

Synopsys (SNPS) has been grinding through a tricky stretch, with the stock sliding over the past 3 months even as revenue and net income keep growing at a double digit clip.

See our latest analysis for Synopsys.

Despite the recent 90 day share price return of minus 25.35 percent, Synopsys still sits on a solid 3 year total shareholder return of 38.77 percent. This suggests longer term momentum has cooled rather than disappeared.

If Synopsys has you rethinking your tech exposure, it could be a good moment to explore other potential winners among high growth tech and AI stocks.

With revenue and earnings still compounding at a healthy clip, and the share price now trading at a discount to Wall Street targets, is Synopsys quietly undervalued, or is the market already baking in its next leg of growth?

Most Popular Narrative: 18.5% Undervalued

With Synopsys closing at $449.35 against a narrative fair value of $551.04, the valuation hinges on aggressive growth and margin expansion over the next few years.

The accelerating complexity and proliferation of AI, high performance computing, and multi die/chiplet based architectures are increasing customer demand for Synopsys' advanced design, verification, and simulation solutions, solidifying its role as a mission critical partner in next generation chip and system development supporting both revenue growth and opportunities for higher margin recurring licensing.

Read the complete narrative.

Curious how this mission critical status translates into future numbers? The narrative leans on rapid scaling, richer margins, and a lofty future earnings multiple. Want the full playbook?

Result: Fair Value of $551.04 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, persistent IP segment weakness and prolonged China export uncertainty could undermine margin expansion and delay the upside that this bullish narrative depends on.

Find out about the key risks to this Synopsys narrative.

Another Lens on Valuation

Step away from narratives and Synopsys looks pricey on plain earnings. The current price to earnings ratio is 73.4 times, versus 64.6 times for peers and 32 times for the wider US software group, and well above our 43.5 times fair ratio. This points to meaningful downside risk if sentiment cools.

See what the numbers say about this price — find out in our valuation breakdown.

Build Your Own Synopsys Narrative

If this perspective does not fully resonate or you would rather dig into the numbers yourself, you can build a personalized narrative in under three minutes, Do it your way.

A great starting point for your Synopsys research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.

Ready for more investment ideas?

Before you move on, secure your next watchlist candidates with our powerful screeners, so you are not leaving high conviction opportunities on the table.

• Target consistent income by reviewing these 14 dividend stocks with yields > 3% that can help anchor your portfolio with reliable cash flows.
• Capitalize on cutting edge innovation by scanning these 24 AI penny stocks shaping the next wave of intelligent software and automation.
• Position for long term upside by checking these 927 undervalued stocks based on cash flows that still look mispriced relative to their cash flow potential.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com